Clinical Trial Results TV
March 18, 2017: Dr. Stephen Ellis and Dr. C. Michael Gibson Discuss: ABSORB III: Everolimus-Eluting Bioresorbable Vascular Scaffolds in
Dr. Stephen Ellis and Dr. C. Michael Gibson Discuss: ABSORB III: Everolimus-Eluting
Bioresorbable Vascular Scaffolds in Patients With Coronary Artery Disease: Two-Year
Outcomes From the ABSORB III Trial

TBD

[ Download video ]


Video Statistics
0 out of 5

1 Star 2 Star 3 Star 4 Star 5 Star

click a star to vote
This submission has received 0 total votes.

These statistics are updated nightly. The last update ran on
10-18-2017 EST at 1 am.

Additional Files
Filename File Description Action
No additional files available

Comments [ login to comment ]
No comments have been submitted